| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $19,491 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Lisi Steven A. | CEO and Chairman of the Board | 1 | $19,491 | 0 | $0 | $19,491 |
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Over the last 12 months, insiders at Beyond Air, Inc. have bought $19,491 and sold $0 worth of Beyond Air, Inc. stock.
On average, over the past 5 years, insiders at Beyond Air, Inc. have bought $2.27M and sold $733,892 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lisi Steven A. (CEO and Chairman of the Board) — $19,491.
The last purchase of 6,000 shares for transaction amount of $19,491 was made by Lisi Steven A. (CEO and Chairman of the Board) on 2025‑07‑21.
| 2025-07-21 | Lisi Steven A. | CEO and Chairman of the Board | 6,000 0.0063% | $3.25 | $19,491 | -59.34% | ||
| 2025-03-14 | Carey Robert | director | 1M 1.0548% | $0.25 | $250,050 | -54.84% | ||
| 2025-02-19 | Gaul Michael A. | Chief Operating Officer | 6,000 0.0072% | $0.38 | $2,294 | -66.01% | ||
| 2024-09-26 | Lisi Steven A. | CEO and Chairman of the Board | 1.48M 4.2606% | $0.50 | $744,662 | -33.58% | ||
| 2024-09-26 | Carey Robert | director | 1.48M 4.2606% | $0.50 | $744,662 | -33.58% | ||
| 2024-08-15 | Lisi Steven A. | CEO and Chairman of the Board | 50,000 0.09% | $0.37 | $18,340 | -11.07% | ||
| 2024-08-14 | Carey Robert | director | 100,000 0.1947% | $0.40 | $39,680 | -16.25% | ||
| 2024-08-14 | Lisi Steven A. | CEO and Chairman of the Board | 100,000 0.1896% | $0.39 | $38,640 | -16.25% | ||
| 2024-08-14 | Lucera Erick | director | 39,266 0.0764% | $0.40 | $15,565 | -16.25% | ||
| 2023-12-28 | Sale | Avniel Amir | Chief Business Officer | 25,000 0.0789% | $2.06 | $51,451 | -69.52% | |
| 2023-12-27 | Sale | Myers Jeff Lynn | Chief Medical Officer | 3,423 0.0107% | $2.21 | $7,579 | -70.76% | |
| 2023-12-18 | Carey Robert | director | 1.2M 3.6746% | $1.64 | $1.96M | -34.34% | ||
| 2023-12-18 | Lisi Steven A. | CEO and Chairman of the Board | 77,775 0.2375% | $1.63 | $126,797 | -34.34% | ||
| 2023-11-16 | Gaul Michael A. | Chief Operating Officer | 10,000 0.0353% | $1.77 | $17,700 | -21.90% | ||
| 2023-08-28 | Carey Robert | director | 250,000 0.7698% | $2.69 | $673,750 | -42.75% | ||
| 2023-08-21 | Carey Robert | director | 75,050 0.236% | $2.76 | $207,453 | -42.75% | ||
| 2023-08-18 | Carey Robert | director | 13,614 0.0424% | $2.64 | $35,940 | -40.75% | ||
| 2023-06-30 | Gaul Michael A. | Chief Operating Officer | 5,000 0.0177% | $4.51 | $22,550 | -58.80% | ||
| 2023-03-31 | Forbes William P | director | 5,000 0.0165% | $6.67 | $33,350 | -64.00% | ||
| 2023-03-30 | Carey Robert | director | 10,000 0.0329% | $6.45 | $64,500 | -62.73% |
| Lisi Steven A. | CEO and Chairman of the Board | 3327411 65.665% | $1.81M | 22 | 4 | +4.75% |
| Carey Robert | director | 4076864 80.4552% | $2.22M | 33 | 0 | <0.0001% |
| Raved Ari | director | 565885 11.1675% | $307,841.44 | 0 | 1 | |
| BENTSUR RON | director | 144736 2.8563% | $78,736.38 | 1 | 26 | <0.0001% |
| Gaul Michael A. | Chief Operating Officer | 94150 1.858% | $51,217.60 | 6 | 0 | <0.0001% |
| Myers Jeff Lynn | Chief Medical Officer | 46577 0.9192% | $25,337.89 | 0 | 1 | |
| Lucera Erick | director | 43608 0.8606% | $23,722.75 | 2 | 0 | <0.0001% |
| BECK DOUGLAS | Chief Financial Officer | 22460 0.4432% | $12,218.24 | 7 | 0 | +40.04% |
| Forbes William P | director | 14855 0.2932% | $8,081.12 | 3 | 0 | <0.0001% |
| Lee Yoori | director | 12654 0.2497% | $6,883.78 | 2 | 0 | <0.0001% |
| Avniel Amir | Chief Business Officer | 0 0% | $0 | 3 | 25 | +5.51% |
| Increased Positions | 8 | +18.6% | 86,706 | +5.04% |
| Decreased Positions | 16 | -37.21% | 309,615 | -17.99% |
| New Positions | 6 | New | 62,001 | New |
| Sold Out Positions | 6 | Sold Out | 62,037 | Sold Out |
| Total Postitions | 35 | -18.6% | 1M | -12.95% |
| Alyeska Investment Group, L.P. | $599.00 | 9.49% | 759,061 | +759,061 | New | 2025-09-30 |
| Balyasny Asset Management L.P. | $366.00 | 5.8% | 464,161 | +297,441 | +178.41% | 2025-09-30 |
| Vanguard Group Inc | $82.00 | 1.31% | 104,409 | +31,814 | +43.82% | 2025-09-30 |
| Bleichroeder Lp | $68.00 | 1.08% | 86,489 | +49,573 | +134.29% | 2025-09-30 |
| Lasry Marc | $65.00 | 1.02% | 81,950 | <1 | <0.01% | 2025-09-30 |
| Kingdon Capital Management, L.L.C. | $37.00 | 0.59% | 46,833 | <1 | <0.01% | 2025-09-30 |
| Geode Capital Management, Llc | $34.00 | 0.54% | 42,983 | +1,067 | +2.55% | 2025-09-30 |
| Wealth Effects Llc | $27.00 | 0.42% | 33,755 | +19,850 | +142.75% | 2025-09-30 |
| Baldwin Wealth Partners Llc/Ma | $24.00 | 0.39% | 30,800 | +15,400 | New | 2025-09-30 |
| Blackrock, Inc. | $17.00 | 0.28% | 22,033 | +<1 | +<0.01% | 2025-09-30 |